August 29, 2024 by Polskie Towarzystwo Lipidologiczne (Polish Lipid Association) Credit: CC0 Public DomainNew research has shown that, contrary to some previous studies, low levels of lipoprotein (a)—a parcel of fats and protein in the blood—do not cause type 2 diabetes. The findings may alleviate concerns that drugs aimed at reducing lipoprotein (a) [known as...
by NIH/National Heart, Lung and Blood Institute Central Illustration. Credit: Journal of the American College of Cardiology (2018). DOI: 10.1016/j.jacc.2017.11.014If you’ve listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, what is...
MASSACHUSETTS GENERAL HOSPITAL BOSTON – Elevated levels of a little-known lipoprotein in the blood that may put people at high risk of cardiovascular disease can be as accurately detected by genetic testing as by conventional laboratory measurement, researchers at Massachusetts General Hospital (MGH) have found. In a study published in JAMA Cardiology, the team reported that genetic risk...
(HealthDay)—For patients with elevated lipoprotein(a) levels and established cardiovascular disease, hepatocyte-directed antisense oligonucleotide AKCEA-APO(a)-LRX (APO(a)-LRX) reduces lipoprotein(a) levels, according to a study published online Jan. 1 in the New England Journal of Medicine. Sotirios Tsimikas, M.D., from the Sulpizio Cardiovascular Center at the University of California, San Diego, and colleagues conducted a randomized, double-blind, placebo-controlled,...
